Skip to main content
. 2007 Jun;61(6):1022–1036. doi: 10.1111/j.1742-1241.2007.01382.x

Figure 6.

Figure 6

The mass median aerodynamic diameter with a peak inhalation flow (A) budesonide and fluticasone propionate and (B) formoterol and salmeterol (the continuous line represents the line of regression for fluticasone and salmeterol, the dashed line for budesonide and formoterol) (reproduced with permission). FP, fluticosone propionate